Enzyme inhibition in drug discovery and development : the good and the bad /

Bibliographic Details
Other Authors: Lu, Chuang, Li, A. P.
Format: Book
Language:English
Published: Hoboken, N.J. : Wiley, [2010]
Subjects:
Table of Contents:
  • The drug discovery process
  • Medicinal chemistry of the optimization of enzyme inhibitors
  • Bioanalytical technologies in drug discovery
  • Safety biomarkers in drug development : emerging trends and implications
  • The role of drug metabolism in drug discovery
  • Applied pharmacokinetics in drug discovery and development
  • Enzyme inhibition and inactivation : cytochrome P450 enzymes
  • Cytochrome P450 induction
  • Inhibition of drug-metabolizing enzymes in gastrointestinal tract and its influence on the drug-drug interaction prediction
  • Enzyme inhibition in various in vitro systems
  • Cytochrome P450 degradation and its clinical relevance
  • Complexities of working with UDP-glucuronosyltransferases (UGTs) : focus on enzyme inhibition
  • Evaluation of inhibitors of drug metabolism in human hepatocytes
  • Grapefruit juice and its constituents as new esterase inhibitors
  • Transporter-xenobiotic interactions : an important aspect of drug development studies
  • Polymorphisms of drug transporters and their clinical implications
  • Clinical drug interactions due to metabolic inhibition : prediction, assessment, and interpretation
  • Predicting interindividual variability of metabolic drug-drug interactions : identifying the causes and accounting for them using a systems approach
  • NF-kB : mechanism, tumor biology, and inhibitors
  • G-protein-coupled receptors as drug targets
  • Pharmacological modulation of ion channels for the treatment of chronic pain
  • Targeting the mTOR pathway for tumor therapeutics
  • HIV-1 protease inhibitors as antiretroviral agents